GNAS1 T393C polymorphism and disease progression in patients with malignant melanoma

BACKGROUND: Once metastasized, despite a variety of therapeutic options, the prognosis of patients with malignant melanoma (MM) is still poor. Therefore, the search for reliable markers to identify patients with high risk of disease progression is of high clinical importance. We have recently shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Frey, UH, Fritz, A, Rotterdam, S, Schmid, KW, Potthoff, A, Altmeyer, P, Siffert, W, Brockmeyer, NH
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352186/
https://www.ncbi.nlm.nih.gov/pubmed/21156401
http://dx.doi.org/10.1186/2047-783X-15-10-422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352186/
https://www.ncbi.nlm.nih.gov/pubmed/21156401
http://dx.doi.org/10.1186/2047-783X-15-10-422

Ejemplares similares